Canada

Alberta restricts puberty blockers and opposite-sex hormones for minors under Ministerial Order 31/2025, with stated exceptions. Sex-reassignment surgery on minors has been banned since December 2024. Schools face limits on lessons or social transition.

Trans Care BC, a Provincial Health Services Authority program, is the provincial pathway for youth puberty blockers and opposite-sex hormones, with BC Children’s Hospital as a hospital site.

Shared Health’s GDAAY program is the public youth pathway for puberty blockers, then opposite-sex hormones.

Youth access opposite-sex hormones through pediatricians and Horizon or Vitalité child-and-youth teams. School rules on preferred first names were tightened, then walked back.

Eastern Health’s Janeway pathway documents puberty blockers and opposite-sex hormones for youth up to 18.

The 2020 Health and Social Services guidelines send children and youth considering puberty blockers or opposite-sex hormones to Stanton Territorial Hospital pediatrics, or to out-of-territory specialists.

The Department of Health and Wellness Gender Affirming Care Policy sets Tanner stage 2 criteria for puberty-blocking agents, and IWK Health is the public pediatric pathway.

Nunavut’s Department of Health funds opposite-sex hormones and listed surgeries. Public pediatric pathways include clinics such as CHEO.

Public pediatric pathways include clinics such as SickKids and CHEO.

Health PEI covers puberty blockers and opposite-sex hormones, and refers under-16s to a pediatrician.

The 2023 MSSS guidelines note opposite-sex hormones and surgeries; public hospital pathways include clinics such as CHU Sainte-Justine.

Saskatchewan’s Ministry of Health covers opposite-sex hormones on the formulary or through Exception Drug Status, through primary care. Bill 137 requires parental consent before staff use a new gender-related preferred name or gender identity for a pupil under 16.

Yukon Insured Health Services covers listed surgeries, hair removal, and voice training.